AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Related Articles
Bitcoin, Ethereum tank on Elon Musk’s latest tweet storm—stocks open the week mixed
Posted on Author admin
U.S. futures are trading sideways on Monday; all the action is in crypto. Read More
Netflix rejects Requires to Include disclaimer to’The Crown’
Posted on Author admin
Netflix has”no plans” to bring a disclaimer into The Crown saying its lavish play around Britain’s imperial household is now currently really a part of fiction. In a statement Saturday, Netflix stated it has ever introduced the play, as only that–a play. “We’ve consistently introduced The Crown for a play –{} have every confidence that […]
Crypto gains as a new Bitcoin-linked ETF sets to begin trading
Posted on Author admin
Global stocks and U.S. futures are under pressure—though off their lows. Read More